2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A
Guideline for Healthcare Professionals From the American Heart Association/American Stroke …

Background: The association of genetic polymorphisms and clopidogrel efficacy in patients
with ischemic stroke or transient ischemic attack (TIA) remains controversial. We performed …

Background Combination antiplatelet therapy with clopidogrel and aspirin may reduce the
rate of recurrent stroke during the first 3 months after a minor ischemic stroke or transient …

Background and Purpose—The purpose of these guidelines is to provide an up-to-date
comprehensive set of recommendations for clinicians caring for adult patients with acute …

Survivors of stroke and transient ischaemic attacks are at risk of a recurrent stroke, which is
often more severe and disabling than the index event. Optimum secondary prevention of …

Background—The Clopidogrel in High-risk patients with Acute Non-disabling
Cerebrovascular Events (CHANCE) trial showed that the combined treatment of clopidogrel …

Stroke is the leading cause of disability in the USA and a major cause of mortality worldwide.
One out of four strokes is recurrent. Secondary stroke prevention starts with deciphering the …

Objective: We aimed to investigate whether the efficacy and safety of clopidogrel plus aspirin
vs aspirin alone were consistent between patients with and without intracranial arterial …

Background: In patients with acute minor ischemic stroke or high-risk transient ischemic
attack enrolled in the POINT trial (Platelet-Oriented Inhibition in New TIA and Minor Ischemic …

Objective Uncertainty remains regarding antithrombotic treatment in cervical artery
dissection. This analysis aimed to explore whether certain patient profiles influence the …